Nitric oxide inhibits the formation of advanced glycation end products

Kidney International

Volumn 58, Issue 4, 2000, Pages 1780-1787

  Asahi, Koichi ^a,b   Ichimori, Kohji ^a,b   Nakazawa, Hiroe ^a,b   Izuhara, Yuko ^a,b   Inagi, Reiko ^a,b   Watanabe, Tsuyoshi ^a,b   Miyata, Toshio ^a,b   Kurokawa, Kiyoshi ^a,b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti oxidant; Chronic renal failure; Glycoxidation; NOC18; Pentosidine; SNAP; Uremia

Indexed keywords

ADVANCED GLYCATION END PRODUCT; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; PENTOSIDINE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; HUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; UREMIA; VASCULAR SMOOTH MUSCLE;

EID: 0033806676     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2000.00340.x     Document Type: Article

References (37)

1. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects
2. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine
3. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia?
4. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of 'carbonyl stress' in long-term uremic complications
5. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia
6. Advanced glycosylation end products in patients with diabetic nephropathy
7. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging
8. Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin- 1
9. Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling
10. Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells
11. Increased aggregation of human platelets produced by advanced glycation end products in vitro
12. Advanced glycation end products increase retinal vascular endothelial growth factor expression
13. 2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: Role of glycoxidation and lipoxidation reactions in vascular tissue damage
14. Role of oxidative stress in development of complications in diabetes
15. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia
16. 2+-induced low density lipoprotein oxidation
17. The formation of some antigenic epitopes in oxidized human low-density lipoprotein is inhibited by nitric oxide
18. Inhibition of low-density lipoprotein oxidation by nitric oxide: Potential role in atherogenesis
19. An unusually stable thionitrite from N-acetyl-D, L-penicillamine: X-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite
20. Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/NO through a radical reaction
21. Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis
22. Hydroxyl radical production and autoxidative glycosylation: Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing
23. The use of Girard-T reagent in a rapid and sensitive methods for measuring glyoxal and certain other alpha-dicarbonyl compounds
24. Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose
25. Mechanism of formation of the Maillard protein cross-link pentosidine: Glucose, fructose, and ascorbate as pentosidine precursors
26. Formation of pentosidine during nonenzymatic browning of proteins by glucose: Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo
27. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure
28. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure
29. The detection of halocarbon-derived radical adducts in bile and liver of rats
30. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids
31. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis
32. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis
33. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products
34. Physiology and biochemistry of endothelial function in children with chronic renal failure
35. Nitric oxide production is reduced in patients with chronic renal failure
36. Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis
37. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure